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Introduction {#cmi12597-sec-0001}
============

Chronic obstructive pulmonary disease (COPD) is often associated with bacterial exacerbations causing increased neutrophil‐triggered inflammation of the airways (Mizgerd, [2008](#cmi12597-bib-0027){ref-type="ref"}; Murphy, [2006](#cmi12597-bib-0028){ref-type="ref"}). *Moraxella catarrhalis*, an exclusively human pathogen of the respiratory tract, is an important causal agent for exacerbations in COPD in adults (Goldstein *et al*., [2009](#cmi12597-bib-0012){ref-type="ref"}). Infections with *M*. *catarrhalis* are responsible for \~10% of all exacerbations in COPD. In addition, the pathogen colonizes the lower respiratory tract in up to 2.5--10% of adults with stable COPD (Goldstein *et al*., [2009](#cmi12597-bib-0012){ref-type="ref"}). In COPD patients, increased numbers of granulocytes are present in the airways, and these are correlated with bacteria‐induced exacerbations and severity of disease (Mizgerd, [2008](#cmi12597-bib-0027){ref-type="ref"}; Stockley, [2002](#cmi12597-bib-0044){ref-type="ref"}). Being phagocytes, granulocytes sense an array of microbial and endogenous ligands and respond dynamically to these signals by producing specific cytokines, such as the macrophage inflammatory protein CCL3 (MIP‐1α) and CXCL8 (interleukin 8), and lipid mediators that orchestrate the resulting immune response (Kasama *et al*., [2005](#cmi12597-bib-0020){ref-type="ref"}; [Thomas and Schroder, [2013](#cmi12597-bib-0045){ref-type="ref"}](#cmi12597-bib-0045){ref-type="ref"}). During infection, granulocyte activation is triggered by pathogen recognition receptors recognizing specific non‐self‐patterns present on many microbes (Amulic *et al*., [2012](#cmi12597-bib-0003){ref-type="ref"}; Drewniak *et al*., [2010](#cmi12597-bib-0010){ref-type="ref"}), leading to the activation of the transcription factor NF‐*κ*B, which controls the expression of inflammatory cytokine genes (Ku *et al*., [2007](#cmi12597-bib-0023){ref-type="ref"}). Increased release of local CXCL8 by human granulocytes contributes to granulocyte accumulation and appropriate antimicrobial activity in the infected tissues (Drewniak *et al*., [2010](#cmi12597-bib-0010){ref-type="ref"}).

*Moraxella catarrhalis* has evolved a distinct surface protein, the ubiquitous surface protein A1 (UspA1), which specifically binds to the amino terminal immunoglobulin variable (Ig~v~)‐like domain of members of the carcinoembryonic antigen‐related cell adhesion molecule (CEACAM) family (Gray‐Owen and Blumberg, [2006](#cmi12597-bib-0013){ref-type="ref"}; Hill and Virji, [2003](#cmi12597-bib-0017){ref-type="ref"}). Receptors belonging to this family mediate intercellular adhesion and various signalling events, modulating inflammation and immune responses associated with the binding of pathogens, as well as growth and/or differentiation of normal and cancer cells (Gray‐Owen and Blumberg, [2006](#cmi12597-bib-0013){ref-type="ref"}; Slevogt *et al*., [2008](#cmi12597-bib-0043){ref-type="ref"}). Human granulocytes express CEACAM1, 3, 4 and the glycosylphosphatidylinositol‐anchored CEACAM6 and 8 (Chen and Gotschlich, [1996](#cmi12597-bib-0007){ref-type="ref"}; Delgado Tascon *et al*., [2015](#cmi12597-bib-0009){ref-type="ref"}; Singer *et al*., [2002](#cmi12597-bib-0037){ref-type="ref"}). Binding of UspA1 to CEACAM1 expressed on human airway epithelium inhibits toll‐like receptor‐2 triggered NF‐*κ*B‐dependent cellular activation via an immunoreceptor tyrosine‐based inhibitory motif in its cytoplasmic domain, allowing the pathogen to escape the inflammatory immune response of the airway mucosa (Schaar *et al*., [2011](#cmi12597-bib-0035){ref-type="ref"}; Slevogt *et al*., [2008](#cmi12597-bib-0043){ref-type="ref"}). In contrast, CEACAM3 is solely expressed on human granulocytes and comprises an immunoreceptor tyrosine‐based activation motif (ITAM)‐like sequence in its cytoplasmic domain (Chen and Gotschlich, [1996](#cmi12597-bib-0007){ref-type="ref"}). This ITAM‐like motif (YxxLx~(7)~YxxM) differs from the conventional ITAM (YxxL/Ix~(6--12)~YxxL/I) by the sequence around the membrane distal tyrosine (YxxM) (Buntru *et al*., [2012](#cmi12597-bib-0006){ref-type="ref"}; Chen and Gotschlich, [1996](#cmi12597-bib-0007){ref-type="ref"}), but also contributes to signalling (Sarantis and Gray‐Owen, [2007](#cmi12597-bib-0033){ref-type="ref"}; Sarantis and Gray‐Owen, [2012](#cmi12597-bib-0034){ref-type="ref"}; Schmitter *et al*., [2004](#cmi12597-bib-0036){ref-type="ref"}). Specific binding of *Neisseria* to CEACAM3 on granulocytes results in the opsonin‐independent phagocytosis of the pathogen‐triggering neutrophil bactericidal activities, such as oxidative burst and degranulation via CEACAM3 tyrosine phosphorylation, Syk kinase recruitment and phosphorylation and NF‐*κ*B activation via PKCδ (Sarantis and Gray‐Owen, [2007](#cmi12597-bib-0033){ref-type="ref"}; Sarantis and Gray‐Owen, [2012](#cmi12597-bib-0034){ref-type="ref"}; Sintsova *et al*., [2014](#cmi12597-bib-0039){ref-type="ref"}). *Moraxella* engagement of CEACAM3 has also been shown to initiate phagocyte effector mechanisms (Buntru *et al*., [2012](#cmi12597-bib-0006){ref-type="ref"}; Schmitter *et al*., [2004](#cmi12597-bib-0036){ref-type="ref"}). The cytoplasmic ITAM‐like sequence of CEACAM3 resembles the hemITAM motif (YxxxL/Ix~(7)~YxxL/I) of Dectin‐1, the major β‐glucan receptor in leukocytes (McDonald *et al*., [2012](#cmi12597-bib-0026){ref-type="ref"}), even though only the membrane proximal tyrosine residue (YxxL) in the hemITAM motif contributes to signalling (Buntru *et al*., [2012](#cmi12597-bib-0006){ref-type="ref"}; Rogers *et al*., [2005](#cmi12597-bib-0031){ref-type="ref"}). In response to ligand engagement, the hemITAM motif of Dectin‐1 becomes tyrosine phosphorylated by Src kinases, providing a docking site for Syk kinase, which links the Dectin‐1 signalling to the CARD9/BCL10/MALT1 complex. Via this distinct signalling pathway, ligation of Dectin‐1 induces the expression of specific cytokines, which are of importance for antifungal immune responses in human monocytes/macrophages and dendritic cells (Reid *et al*., [2009](#cmi12597-bib-0030){ref-type="ref"}; Ruland, [2008](#cmi12597-bib-0032){ref-type="ref"}). We hypothesized that *M. catarrhalis* also activates the CARD9 pathway via CEACAM3 in a Syk‐dependent manner leading to NF‐*κ*B activation and increased cytokine responses of human neutrophils.

Results {#cmi12597-sec-0002}
=======

Moraxella catarrhalis interacts with human granulocytes {#cmi12597-sec-0003}
-------------------------------------------------------

Scanning electron microscopy reveals that *M*. *catarrhalis* possesses the ability to substantially bind to the surface of human granulocytes (Supplementary [Fig. 1](#cmi12597-supitem-0001){ref-type="supplementary-material"}). Two, four and six hours after infection, the bacteria form multi‐cellular, grape‐like aggregates on the cell surface. Bilker *et al.* and Buntru *et al.* showed a CEACAM3‐mediated formation of lamellipodia on CEACAM3‐expressing HeLa cells and primary human granulocytes leading to efficient engulfment of *Neisseria gonorrhoeae* (Billker *et al*., [2002](#cmi12597-bib-0004){ref-type="ref"}; Buntru *et al*., [2012](#cmi12597-bib-0006){ref-type="ref"}). As shown in Supplementary [Fig. 1E and F](#cmi12597-supitem-0001){ref-type="supplementary-material"}, we found membrane protrusions around bacterial‐binding sites which, to some extent, resemble lamellipodia‐like structures suggesting a CEACAM3‐dependent uptake. As expected, transmission electron microscopy graphs also demonstrate phagocytosed *M*. *catarrhalis* within granulocytes 6 h post‐infection (Fig. [1](#cmi12597-fig-0001){ref-type="fig"}A and B, Supplementary [Fig. 4A](#cmi12597-supitem-0004){ref-type="supplementary-material"}). Bacterial activity as determined by ribosome content was carried out using fluorescence *in situ* hybridisation. Untreated granulocytes (data not shown) or bacteria alone served as controls (Supplementary [Fig. 2](#cmi12597-supitem-0002){ref-type="supplementary-material"}). Remarkably as shown in Fig. [1](#cmi12597-fig-0001){ref-type="fig"}C after 4 h of bacterial incubation, *M*. *catarrhalis* cells were still located in association with the cell‐surface as well as within the granulocytes suggesting a close and prolonged interaction of *M*. *catarrhalis* with CEACAM3 on the cell membrane of granulocytes.

![*Moraxella catarrhalis* binding and phagocytosis by human granulocytes. A, B. Transmission electron micrographs (TEM) of phagocytosis of *M*. *catarrhalis* strain BBH18 (arrow) by human granulocytes 6 h post‐infection (MOI 50). Bar represents 2 µm. C. Fluorescence *in situ* hybridisation (FISH) after 4 h of infection using pan‐bacterial probe EUB 338Cy3 (orange: FISH positive bacteria; green: granulocyte auto‐fluorescence; blue: DAPI‐stained host cell DNA and bacterial DNA). Nonsense binding of the probes was excluded using NON‐EUB338Cy5 (data not shown). Note the FISH positive clusters of bacteria attached to the cells. As shown by the cross section of the z‐stack (white lines, side view between red and blue lines), also within the cells, FISH‐positive bacteria can be identified. Data are from one experiment.](CMI-18-1570-g001){#cmi12597-fig-0001}

Moraxella UspA1‐CEACAM3 interaction elicits oxidative burst and degranulation of human granulocytes {#cmi12597-sec-0004}
---------------------------------------------------------------------------------------------------

We tested the binding abilities of *M*. *catarrhalis* BBH18 wild‐type and UspA1 deletion strains to recombinant CEACAM1, 3, 6 and 8‐FC fusion proteins using a pull‐down assay. The wild‐type strain binds significantly to recombinant CEACAM1, 3 and 6, whereas, there is no binding to CEACAM8 and the CEACAM1‐ΔN mutant lacking the N‐terminal Ig‐domain responsible for the CEACAM1‐UspA1 interaction (Fig. [2](#cmi12597-fig-0002){ref-type="fig"}A). Further, we confirmed by sequence analysis that the UspA1 protein from *M*. *catarrhalis* BBH18 used in this study had the complete CEACAM‐binding region as demonstrated by Brooks *et al.* (Brooks *et al*., [2008](#cmi12597-bib-0005){ref-type="ref"}) (Supplementary [Fig. 3](#cmi12597-supitem-0003){ref-type="supplementary-material"}).

![Granulocytic CEACAM3 is essential for oxidative burst, degranulation and chemokine release in response to *Moraxella*‐UspA1. A. Pull down: BBH18 wild‐type bacteria and the UspA1‐deficient mutant BBH18.1 were incubated with CEACAM proteins as described in the Materials and Methods section. 10% of inputs, 10% of supernatants (unbound proteins) and 50% of eluates (bound proteins) were analysed by Western blot using a pan‐human CEACAM cross‐reactive anti‐CEA antibody (DAKO). Note the binding of CEACAM1, CEACAM3 and CEACAM6 to the wild‐type bacteria only and the absence of any binding of CEACAM8 and the CEACAM1‐ΔN mutant lacking the N‐terminal Ig‐domain responsible for the CEACAM1‐UspA1 interaction. B. CEACAM3‐specific degranulation in response to *Moraxella* infection. Cells were incubated with Cytochalasin B prior to infection with *Moraxella catarrhalis* BBH18 or the UspA1 deletion strain (1 h, MOI 50) alone or after pre‐incubation (1 h, 30 µg/ml) with the CEACAM3‐blocking antibody \[Col‐1\] as well as CEACAM1‐ or CEACAM6‐blocking antibodies. Supernatants were collected and analysed for myeloperoxidase (MPO) release, as described in Material and Methods. The untreated control has been set to 100%. C. Oxidative burst determined by Dichlorofluorescein (DCF)‐dependent fluorescence of granulocytes stimulated for 1 h with *M. catarrhalis* wild‐type strain BBH18 (MOI 100) or the corresponding, UspA1 deletion strain (MOI 100) alone or after preincubation (1 h) with the CEACAM3‐blocking antibody \[Col‐1\] or a CEACAM1‐blocking antibody. PMA served as positive control, unstimulated cells served as negative control (unfilled). D. CXCL8 or (E) CCL3 were determined by ELISA in supernatants of human granulocytes stimulated for 16 h with Pam3Cys (1 µg/ml), *M*. *catarrhalis* strain BBH18 (MOI 50) alone or after pre‐incubation (1 h, 30 µg/ml) with the CEACAM3‐blocking antibody \[Col‐1\], CEACAM1‐, CEACAM6‐blocking antibodies or IgG2a control antibody. Data are representative from one out of three experiments (A, C) or represent mean and SD of at least three (B, D, E) experiments done in duplicates (*p* \< 0.05).](CMI-18-1570-g002){#cmi12597-fig-0002}

Granulocyte ROS production was assessed using a flow cytometry‐based protocol measuring the oxidation of non‐fluorescent 2′,7′‐Dichlorodihydrofluorescin diacetate (DCFH‐DA) to highly fluorescent 2′,7′‐Dichlorodihydrofluorescein (DCF). We found that the *Moraxella* UspA1‐CEACAM3 interaction possesses substantial importance for the reactive oxygen species release of human granulocytes. Inhibition of the UspA1‐CEACAM3 interaction with the CEACAM3‐blocking antibody Col‐1 (Chen and Gotschlich, [1996](#cmi12597-bib-0007){ref-type="ref"}), as well as infection of the granulocytes with an UspA1‐deleted mutant strain of *M*. *catarrhalis*, which is unable to bind CEACAM, resulted in a significant decrease in ROS production (Fig. [2](#cmi12597-fig-0002){ref-type="fig"}C). Perturbation of the CEACAM3‐UspA1 interaction, using the CEACAM3‐blocking antibody Col‐1, also significantly reduced the granulocyte degranulation, as shown by evaluation of myeloperoxidase release into the granulocyte supernatants (Fig. [2](#cmi12597-fig-0002){ref-type="fig"}B).

Moraxella UspA1‐CEACAM3 interactions increase chemokine secretion {#cmi12597-sec-0005}
-----------------------------------------------------------------

To investigate functional effects of the interaction between *M*. *catarrhalis* UspA1 and CEACAM3, the amount of CXCL8 released by human granulocytes was measured in response to stimulation with *M*. *catarrhalis* strain BBH18 alone or after pre‐incubation with the CEACAM3‐blocking antibody Col‐1 (Fig. [2](#cmi12597-fig-0002){ref-type="fig"}D). The TLR2 agonist Pam3Cys was used as a positive control. We found that human granulocytes pre‐treated with the CEACAM3‐blocking antibody displayed a significant reduction in CXCL8 response when infected with BBH18 *M*. *catarrhalis* wild‐type strain compared with cells without pre‐treatment. The pro‐inflammatory effect due to the interaction of CEACAM3 with *M*. *catarrhalis* was not affected by the presence of antibodies targeting the other CEACAM receptors or control IgG antibody (Fig. [2](#cmi12597-fig-0002){ref-type="fig"}D). There was also no influence of CEACAM3‐blocking on *Moraxella* UspA1 deletion mutant‐induced CXCL8 secretion (data not shown). In addition, secretion of the granulocyte‐activating chemokine macrophage inflammatory protein CCL3 (MIP‐1α), was also CEACAM3‐dependent because blocking of CEACAM3 prior to infection with *M*. *catarrhalis* also led to a decreased amount of CCL3 in the supernatants (Fig. [2](#cmi12597-fig-0002){ref-type="fig"}E).

Because of their short lifespan, human granulocytes are not suitable for prolonged assays such as RNA interference. Therefore, for further experiments in which we aimed to study the mechanisms of the *M*. *catarrhalis*‐induced CEACAM3‐dependent cytokine secretion, we used the promyelocytic cell line NB4. Flow cytometry revealed the lack of any CEACAM3 expression on the surface of untreated NB4 cells (Fig. [3](#cmi12597-fig-0003){ref-type="fig"}A). Treatment with 2 μM all‐trans retinoic acid (ATRA) for 72 h led to cell differentiation indicated by *de novo* CEACAM3 and enhanced CD11b expression. RT‐PCR demonstrated that both undifferentiated and differentiated NB4 cells as well as human granulocytes express the major proteins of the investigated pathway, namely Syk kinase, CARD9, BCL10 and MALT1 (Supplementary [Fig. 4B](#cmi12597-supitem-0004){ref-type="supplementary-material"}). All‐trans retinoic acid‐differentiated, but not undifferentiated, NB4 cells also express CEACAM1, 6 and 8 (data not shown, Jacobi, [2008](#cmi12597-bib-0018){ref-type="ref"}). However, because these receptors are not involved in the induction of the pro‐inflammatory ITAM/Syk/CARD9‐dependent signalling pathways (Gray‐Owen and Blumberg, [2006](#cmi12597-bib-0013){ref-type="ref"}; Kuespert *et al*., [2006](#cmi12597-bib-0024){ref-type="ref"}), we used undifferentiated as well as differentiated NB4 cells as suitable cell models to investigate the pathways that are attributed to ITAM‐dependent signalling.

![Role of CEACAM3 ITAM in *Moraxella catarrhalis* UspA1‐induced CXCL8 release in NB4 cells. A. Flow cytometry of CEACAM3 and CD11b expression on the surface of untreated and all‐trans retinoic acid (ATRA)‐differentiated NB4 cells. Mouse IgG1 antibody was used as an isotype control. B. Flow cytometry data of CEACAM3 knock‐down efficiency (grey line: isotype control, thick line: control‐siRNA‐treated cells or CEACAM3‐siRNA treated cells) and ELISA of CXCL8 in supernatants of ATRA‐differentiated NB4 cells transfected for 96 h with control or CEACAM siRNA, and subsequently infected with *M*. *catarrhalis* strain BBH18 (MOI 50) for 16 h. C. ELISA of CXCL8 in supernatants of NB4 cells transiently transfected with control vector or wild‐type CEACAM3 left untreated or incubated for 16 h with the *M*. *catarrhalis* wild‐type strain BBH18 or ∆UspA1 mutant strain BBH18.1 (MOI 50). D. ELISA of CXCL8 in supernatants of NB4 cells. Cells were transiently transfected with CEACAM3 wt, CEACAM3 Y230F, CEACAM3 Y241F or control vector, then left untreated or stimulated for 16 h with *M*. *catarrhalis* strain BBH18 (MOI 50). Uninfected cells transfected with control vector have been set to 1 (range 246‐1323 pg/ml). Data are representative from one of three independent experiments (A) or are from at least three experiments (mean ± SD) performed in duplicates (B, C) (*p* \< 0.05).](CMI-18-1570-g003){#cmi12597-fig-0003}

To test for the impact of CEACAM3 on *M*. *catarrhalis*‐induced CXCL8 secretion, we performed siRNA‐mediated knock‐down of CEACAM3 in ATRA‐differentiated NB4 cells followed by *M*. *catarrhalis* infection for 16 h. Compared with control si‐transfected cells, the CXCL8 secretion was significantly reduced (Fig. [3](#cmi12597-fig-0003){ref-type="fig"}B). In a further experiment, undifferentiated NB4 cells were transiently transfected with control vector or wild‐type CEACAM3, and infected with BBH18 wild‐type strain or UspA1 deletion mutant strain. The UspA1‐deficient strain showed a substantially reduced release of CXCL8 compared with the wild‐type strain (Fig. [3](#cmi12597-fig-0003){ref-type="fig"}C).

To investigate the importance of the CEACAM3 ITAM‐like domain for *M*. *catarrhalis*‐induced chemokine secretion, we used CEACAM3 tyrosine mutants generated by substitution of the tyrosine residues 230 or 241 with phenylalanine (Y230F, Y241F). Transiently transfected NB4 cells were stimulated with *M*. *catarrhalis* for 16 h. Only cells expressing wild‐type CEACAM3 showed a significant increase in CXCL8 secretion compared with control vector, whereas, there was no change in cytokine release in NB4 cells expressing CEACAM3 tyrosine mutants (Fig. [3](#cmi12597-fig-0003){ref-type="fig"}D). Similar expression levels of CEACAM3 mutant and wild‐type protein were assessed by flow cytometry (data not shown). Collectively, our data suggest that the interaction of UspA1 with CEACAM3 increases the *M*. *catarrhalis*‐induced inflammatory immune response of human granulocytes. This increase is dependent on phosphorylatable tyrosine residues within the ITAM‐like motif of the CEACAM3 cytoplasmic domain.

Moraxella UspA1‐CEACAM3‐induced CXCL8 secretion in human granulocytes is Syk‐dependent {#cmi12597-sec-0006}
--------------------------------------------------------------------------------------

Binding of Opa‐expressing *Neisseria* to CEACAM3 results in CEACAM3 tyrosine phosphorylation, Syk recruitment and Syk phosphorylation (Sarantis and Gray‐Owen, [2007](#cmi12597-bib-0033){ref-type="ref"}). We investigated whether a similar mechanism is induced by *M*. *catarrhalis*. As shown by co‐immuno‐precipitation experiments in Fig. [4](#cmi12597-fig-0004){ref-type="fig"}A, *Moraxella* treatment led to a direct CEACAM3‐Syk interaction in ATRA‐differentiated NB4 cells. *Moraxella* treatment also induced an increase in phosphorylated Syk in human primary granulocytes, while the total amount of Syk was not influenced (Fig. [4](#cmi12597-fig-0004){ref-type="fig"}A and B). To test for the functional relevance of Syk phosphorylation, human granulocytes were stimulated with *M. catarrhalis* alone or after pre‐incubation with the Syk kinase inhibitor R406. Syk kinase inhibition resulted in significantly lower CXCL8 release (Fig. [4](#cmi12597-fig-0004){ref-type="fig"}C). We further confirmed the impact of Syk by transfecting ATRA‐differentiated NB4 cells with either a Syk‐specific siRNA or a control siRNA; knock‐down efficiency was confirmed by Western blot. Stimulation of the Syk‐specific siRNA‐transfected NB4 cells with *M. catarrhalis* resulted in significantly reduced CXCL8 production compared with the cells transfected with control siRNA (Fig. [4](#cmi12597-fig-0004){ref-type="fig"}D).

![*Moraxella catarrhalis*‐induced CXCL8 release is partially dependent on Syk phosphorylation. A. Immunoblot analysis of Syk‐CEACAM3 co‐immunoprecipitation. Syk and CEACAM3 were assessed in lysates of ATRA differentiated NB4 cells stimulated with *M. catarrhalis* (MOI 50) after immunoprecipitation of CEACAM. B. Flow cytometry of total Syk and phosphorylated Syk (p‐Syk) in human granulocytes left untreated (filled histogram) or incubated with *M*. *catarrhalis* (MOI 50) for 2 min (black line) or 5 min (grey line), and isotype control (dotted line). C. ELISA of CXCL8 in supernatants of granulocytes left untreated or incubated for 16 h with BBH18 (MOI 50) with and without pre‐incubation for 1 h with the Syk kinase inhibitor R406 (1 μM). D. Immunoblot analysis of gene‐silencing efficiency in ATRA‐differentiated NB4 cells transfected for 72 h with control siRNA (c‐si) or Syk‐specific siRNA (Syk‐si), and ELISA of CXCL8 in supernatants of ATRA‐differentiated NB4 cells transfected for 72 h with control or Syk‐specific siRNA, and subsequently infected with *M*. *catarrhalis* strain BBH18 (MOI 50) for 16 h. Data are representative from one of three independent experiments (A, B) or are from three experiments (mean ± SD) done in duplicates (C, D) (*p* \< 0.05).](CMI-18-1570-g004){#cmi12597-fig-0004}

CARD9 is essential for the CEACAM3‐mediated Moraxella catarrhalis‐induced NF‐κB activation in human granulocytes {#cmi12597-sec-0007}
----------------------------------------------------------------------------------------------------------------

Because the hemITAM‐bearing receptor Dectin‐1 enables NF‐*κ*B activation and subsequent CXCL8 expression via Syk recruitment and CARD9 activation (Gross *et al*., [2006](#cmi12597-bib-0014){ref-type="ref"}), we further investigated the impact of CARD9 on *Moraxella*‐induced CEACAM3‐dependent CXCL8 secretion.

Expression of CARD9 was inhibited by siRNA in ATRA‐differentiated NB4 cells. The knock‐down efficiency of the CARD9‐specific siRNA was confirmed by qPCR (Fig. [5](#cmi12597-fig-0005){ref-type="fig"}A). Downregulation of CARD9 expression resulted in significantly reduced CXCL8 secretion induced by *M. catarrhalis* compared with control siRNA‐transfected NB4 cells, confirming the involvement of CARD9 in *M*. *catarrhalis*‐induced CXCL8 release (Fig. [5](#cmi12597-fig-0005){ref-type="fig"}B).

![CARD9 is required for the *M*. *catarrhalis*‐induced CXCL8 release in NB4 cells. A. Gene‐silencing abilities of the CARD9 and control RNA duplexes in ATRA‐differentiated NB4 cells were assessed by qPCR analysis 72 h post‐transfection, shown as relative quantification (RQ). B. ATRA‐differentiated NB4 cells were transfected with the siRNAs as indicated for 72 h and subsequently infected with *M*. *catarrhalis* strain BBH18 (MOI 50) for 16 h. CXCL8 concentrations in the supernatants were analysed by ELISA. Data represent mean ± SD of at least three individual experiments performed in duplicates \* p \< 0.05 C. Luciferase activity in HEK293 cells transiently co‐transfected with CARD9/BCL10 or CEACAM3 wild‐type, CEACAM3 Y230F, CEACAM3 Y241F or control vector along with an NF‐*κ*B‐driven luciferase reporter plasmid and a Renilla luciferase reporter plasmid, then left untreated or stimulated for 5 h with *M*. *catarrhalis* strain BBH18 (MOI 50). Relative luciferase activities (relative luciferase units, RLU) were obtained and are presented as percent of control (uninfected cells transfected with CARD9, BCL10 and CEACAM3 were set to 100%). Columns represent mean ± SD of three independent experiments done in triplicates (*p* \< 0.05).](CMI-18-1570-g005){#cmi12597-fig-0005}

To verify the association between CEACAM3 and the CARD9‐dependent signalling pathway, we used an NF‐*κ*B reporter gene model previously described by Gross *et al.* (Gross *et al*., [2006](#cmi12597-bib-0014){ref-type="ref"}). HEK293 cells were transiently co‐transfected with a NF‐*κ*B luciferase reporter plasmid and either empty or CEACAM3‐, or CARD9‐/BCL10‐encoding expression plasmids. Co‐transfection with CEACAM3 or control vector alone did not result in reporter gene activation. In these cells, also *M*. *catarrhalis* infection failed to induce NF‐*κ*B. As has already been described before (Gross *et al*., [2006](#cmi12597-bib-0014){ref-type="ref"}), HEK293 cells transfected with CARD9‐and BCL10‐encoding vectors alone displayed an increased NF‐*κ*B activation as a background signal, which was independent of bacterial stimulation. Importantly, cells expressing CEACAM3 in addition to CARD9 and BCL10 demonstrated a significantly enhanced NF‐*κ*B activation following infection with *M*. *catarrhalis* (Fig. [5](#cmi12597-fig-0005){ref-type="fig"}C). In contrast, there was no NF‐*κ*B activation in HEK293 cells expressing CARD9, BCL10 and CEACAM3 tyrosine mutants.

NF‐*κ*B (p65 and c‐Rel) binding followed by polymerase II recruitment to the *CXCL8* promotor region was verified by chromatin immunoprecipitation analysis in granulocytes infected with *M*. *catarrhalis* (Fig. [6](#cmi12597-fig-0006){ref-type="fig"}). Perturbation of the CEACAM3‐UspA1 interaction by the CEACAM3‐blocking antibody Col‐1 inhibited the binding of transcription factors p65 and c‐Rel as well as the recruitment of the polymerase II to the *CXCL8* promoter. The CEACAM1‐blocking antibody serves as a control, there was no inhibition of p65, c‐Rel or polymerase II observed.

![*Moraxella catarrhalis*‐induced recruitment of NF‐*κ*B to the *CXCL8* promotor region is CEACAM3‐dependent. Human granulocytes were stimulated for 1 h with *M*. *catarrhalis* strain BBH18 (MOI 50) with or without pre‐incubation (1 h) with the CEACAM3‐blocking antibody \[Col‐1\] or CEACAM1‐blocking antibody and promoter localization of c‐Rel, p65 and Pol II were assessed by PCR after chromatin immunoprecipitation (ChIP) (A). DNA gels were scanned and quantified. Bars represent mean ± SD from three independent experiments (B).](CMI-18-1570-g006){#cmi12597-fig-0006}

Discussion {#cmi12597-sec-0008}
==========

Most studies investigating the impact of CEACAM3 on opsonin‐independent phagocytosis of granulocytes have focused on the interaction with colony opacity‐associated (Opa) expressing *N*. *gonorrhoeae* (Chen and Gotschlich, [1996](#cmi12597-bib-0007){ref-type="ref"}; Pils *et al*., [2012](#cmi12597-bib-0029){ref-type="ref"}; Sarantis and Gray‐Owen, [2007](#cmi12597-bib-0033){ref-type="ref"}; Sarantis and Gray‐Owen, [2012](#cmi12597-bib-0034){ref-type="ref"}; Schmitter *et al*., [2004](#cmi12597-bib-0036){ref-type="ref"}). Schmitter *et al*. ([2004](#cmi12597-bib-0036){ref-type="ref"}) demonstrated that *M*. *catarrhalis* is, likewise, recognized and phagocytosed via CEACAM3 (Schmitter *et al*., [2004](#cmi12597-bib-0036){ref-type="ref"}). In the present study, we have demonstrated that the interaction of *M*. *catarrhalis* UspA1 with CEACAM3 is important for its ability to elicit oxidative burst and degranulation responses in human granulocytes. Our results are in agreement with recent findings that demonstrated the importance of the CEACAM3‐binding properties of *N*. *gonorrhoeae* for the induction of oxidative burst in infected granulocytes (Sarantis and Gray‐Owen, [2012](#cmi12597-bib-0034){ref-type="ref"}). *M*. *catarrhalis* binds to cell surfaces of pulmonary epithelial cells forming multi‐cellular, grape‐like aggregates and interacts with cell surface receptors (Aebi *et al*., [1998](#cmi12597-bib-0002){ref-type="ref"}; Gray‐Owen and Blumberg, [2006](#cmi12597-bib-0013){ref-type="ref"}; Hill and Virji, [2003](#cmi12597-bib-0017){ref-type="ref"}; Slevogt *et al*., [2006b](#cmi12597-bib-0041){ref-type="ref"}; Slevogt *et al*., [2007](#cmi12597-bib-0042){ref-type="ref"}; Slevogt *et al*., [2008](#cmi12597-bib-0043){ref-type="ref"}). In our study, we found similar *M*. *catarrhalis* aggregate formation on human granulocytes.

Recently, Sintsova *et al*. ([2014](#cmi12597-bib-0039){ref-type="ref"}) demonstrated that *N*. *gonorrhoeae*--CEACAM3 interaction triggers a Syk‐, PKCδ‐ and Tak1‐dependent signalling pathway, which results in the activation of an NF‐κB‐dependent transcriptional response with subsequent production of pro‐inflammatory cytokines. Although CEACAM3 is mainly known as a phagocytic receptor, phagocytosis and oxidative burst are not essential for inflammatory cytokine release (Sintsova *et al*., [2014](#cmi12597-bib-0039){ref-type="ref"}). Importantly, we have demonstrated that in human granulocytes *M*. *catarrhalis*‐induced CEACAM3 signalling was linked to NF‐*κ*B activation via the CARD9 pathway, which resulted in increased cytokine release (proposed model in Supplementary [Fig. 5](#cmi12597-supitem-0005){ref-type="supplementary-material"}). CEACAM3‐mediated signalling was initiated via its ITAM‐like motif in the cytoplasmic domain and activation of Syk. A similar mechanism is used by Dectin‐1, which is also linked to NF‐*κ*B activation and cytokine production via Syk and the CARD9/BCL10/MALT1 signalosome (Gross *et al*., [2006](#cmi12597-bib-0014){ref-type="ref"}; Hara and Saito, [2009](#cmi12597-bib-0015){ref-type="ref"}; Ruland, [2008](#cmi12597-bib-0032){ref-type="ref"}). Our data suggest a direct recruitment of Syk to phosphorylated CEACAM3 ITAM, because Syk co‐immuno precipitates with CEACAM3 on infection with *M*. *catarrhalis* (this study) and *N*. *gonorrhoeae* (Sarantis and Gray‐Owen, [2012](#cmi12597-bib-0034){ref-type="ref"}). Mutation of either tyrosine (Y230F or Y241F) in the CEACAM3 ITAM is sufficient to lose CEACAM3‐dependent CXCL8 release.

Most studies investigating the functional role of the CARD9/BCL10/MALT1 signalosome focused on dendritic cells or monocytes/macrophages (Gross *et al*., [2006](#cmi12597-bib-0014){ref-type="ref"}; Hara and Saito, [2009](#cmi12597-bib-0015){ref-type="ref"}; Kerrigan and Brown, [2009](#cmi12597-bib-0021){ref-type="ref"}; Ruland, [2008](#cmi12597-bib-0032){ref-type="ref"}; Wegener and Krappmann, [2007](#cmi12597-bib-0046){ref-type="ref"}). Nevertheless, it was shown that, during inflammation, human granulocytes are also a major source of cytokines (Jaillon *et al*., [2013](#cmi12597-bib-0019){ref-type="ref"}; Mantovani *et al*., [2011](#cmi12597-bib-0025){ref-type="ref"}). Besides CEACAM3, as discussed earlier (Sintsova *et al*., [2014](#cmi12597-bib-0039){ref-type="ref"}), only a few reports address the impact of ITAM‐bearing receptors in cytokine induction. In a murine model activation of the neutrophilic ITAM‐associated receptor CLEC5A sensitized by sterile liver injury caused lethal TNFα production (Cheung *et al*., [2011](#cmi12597-bib-0008){ref-type="ref"}). Another study demonstrated the functional importance of CARD9 expressed in granulocytes, showing that granulocytes derived from CARD9‐deficient patients exhibit defects in inflammatory cytokine production (Drewniak *et al*., [2013](#cmi12597-bib-0011){ref-type="ref"}). Therefore, the induction of cytokines via CARD9/BCL10/MALT1 signalosome by ITAM‐associated receptors expressed on granulocytes may be of great importance for the orchestration of immune responses targeting specific pathogens.

In summary, our study provides evidence that *Moraxella* UspA1 induces numerous neutrophil activation responses by interacting with CEACAM3. The identification of CEACAM3 as a receptor for *M*. *catarrhalis* UspA1 activating granulocytes via the CARD9 pathway provides the first evidence of non‐redundant signalling that might be crucial for the pro‐inflammatory immune response of granulocytes in COPD. Further understanding of the impact of CEACAM3 is necessary, as it may represent a therapeutic target for modulating the inflammatory immune responses during *M*. *catarrhalis*‐induced exacerbations, as well as its pathological colonization of the lower airways in COPD patients.

Experimental procedures {#cmi12597-sec-0009}
=======================

Reagents and antibodies {#cmi12597-sec-0010}
-----------------------

Pam~3~Cys was obtained from EMC microcollections (Tübingen, Germany), and the Syk kinase Inhibitor R406 was purchased from InvivoGen (Toulouse, France). Monoclonal antibodies: anti‐CEACAM3/CEA antibody \[Col‐1\] (Abcam, Cambridge, UK or Santa Cruz Biotechnology, Heidelberg, Germany); anti‐CEACAM3/CEA antibody 308/3‐3, anti‐CEACAM1/CEA antibody 18/20 and anti‐CEACAM6 antibody 1H7‐4B (B.B. Singer, Essen Germany); anti‐Syk antibody \[4D10.1\] (Chemicon International, Millipore, Schwalbach/Ts., Germany or Santa Cruz Biotechnology, Heidelberg, Germany) and anti‐phospho Syk (Santa Cruz Biotechnology, Heidelberg, Germany); anti‐CD11b antibody (STEMCELL Technologies SARL, Köln, Germany); mouse IgG1 and IgG2a isotype control (ebioscience, Frankfurt/Main, Germany). Polyclonal antibodies: Phycoerythrin (PE) labelled goat‐anti‐mouse antibody (H + L, antibodies‐online GmbH, Aachen, Germany). Antibodies for chromatin immunoprecipitation: anti‐NF‐κB p65, anti‐NF‐κB c‐Rel and anti‐polymeraseII (Santa Cruz Biotechnology, Heidelberg, Germany).

Bacterial strains {#cmi12597-sec-0011}
-----------------

The European clinical isolate strain *M. catarrhalis* BBH18 and the UspA1‐deficient mutant BBH18.1 (selected with 1.5 µg/ml of chloramphenicol) were provided by K. Riesbeck (Lund University, Sweden). Bacteria were cultured as described (Slevogt *et al*., [2006a](#cmi12597-bib-0040){ref-type="ref"}).

Human cells and cell lines {#cmi12597-sec-0012}
--------------------------

Human granulocytes were isolated from EDTA‐treated peripheral blood taken from healthy volunteers using 1‐Step® Polymorphs (Accuratechemical, NY, USA), according to the manufacturer\'s protocol. Granulocytes were then resuspended at 10^7^ cells ml^−1^ in DMEM (Gibco, Life Technologies GmbH, Darmstadt, Germany). Donors signed a written informed consent form. This procedure was approved by the Ethics Committee of the Medical Faculty of the Charité -- Universitätsmedizin Berlin.

NB4 cells were purchased from Creative Bioarray (Cambridge, UK) and were grown in RPMI 1640 medium (PAA Laboratories, Parsching, Austria) supplemented with 10% FCS. NB4 differentiation was induced with 2 μM of ATRA in normal growth medium for 3 days. For infection, cells were re‐suspended at 10^6^ cells ml^−1^ medium.

HEK293 were obtained from DSMZ (Braunschweig, Germany) and were grown in DMEM (high‐glucose) (Gibco, Life Technologies GmbH, Darmstadt, Germany) supplemented with 10% FCS.

Electron microscopy {#cmi12597-sec-0013}
-------------------

Human granulocytes were fixed in 2.5% of glutaraldehyde in phosphate buffer (0.06 M, pH 7.3). Cells were analysed by scanning electron microscopy as has been described (Slevogt *et al*., [2007](#cmi12597-bib-0042){ref-type="ref"}).

Fluorescence in situ hybridisation {#cmi12597-sec-0014}
----------------------------------

Fluorescence *in situ* was performed as has been described in Supplementary Material.

Pull down {#cmi12597-sec-0015}
---------

BBH18 and the UspA1‐deficient mutant BBH18.1 were plated overnight on Columbia agar (BD Biosciences) and were grown for 2 h at 37 °C in 50 ml of Brain Heart infusion broth (BHI, BD Biosciences). Recombinant extracellular domains of human CEACAM proteins (CEACAM1‐Fc, CEACAM1‐deltaN‐Fc, CEACAM3‐Fc, CEACAM6‐Fc and CEACAM8‐Fc; (Klaile *et al*., [2009](#cmi12597-bib-0022){ref-type="ref"}; Singer *et al*., [2014](#cmi12597-bib-0038){ref-type="ref"}) were treated with one volume 100 mM of glycine pH 2.2 for 10 min at room temperature followed by the addition of one volume 1 M of Tris--HCl pH 8.3. Bacteria were washed twice in PBS, and pellets were incubated with 2 µg of the respective proteins in 100 µl of PBS for 3 h on a rotator at 4 °C. Supernatants with unbound proteins were removed and the pellets were washed twice with 1 ml of PBS. Proteins bound to the bacteria were eluted by the addition of 40 µl 100 mM of glycine pH 2.2, and the pH was restored by the addition of 10 µl 1 M of Tris--HCl pH 8.3. Samples were analysed for the presence of CEACAMs by Western blot using rabbit anti‐CEA antibody (DAKO).

Enzyme‐linked immunosorbent assay {#cmi12597-sec-0016}
---------------------------------

The cytokine secretion of NB4 cells and granulocytes was quantified using commercially availableEnzyme‐linked immunosorbent assay (ELISA) kits (Human IL‐8 ELISA Set, BD Biosciences, Heidelberg, Germany; Human MIP‐1α ELISA kit, Thermo Scientific) according to the manufacturer\'s protocols. Measurements were made in a Tecan plate reader.

RNA‐mediated interference and plasmid transfection {#cmi12597-sec-0017}
--------------------------------------------------

NB4 cells were transfected with a Lonza Nucleofector Kit (Lonza, Köln, Germany) according to the manufacturer\'s protocol with small interfering (si)RNA (s13681, s34526 Ambion, life technologies GmbH, Darmstadt, Germany) or plasmid DNA (Entelechon, Regensburg, Germany). Seventy‐two hours after transfection, cells were infected with *M*. *catarrhalis*, and CXCL8 release was measured by ELISA.

HEK293 cell luciferase reporter assay {#cmi12597-sec-0018}
-------------------------------------

Plasmids: pcDNA3.1 -- wild‐type CEACAM3 (Entechelon, Regensburg, Germany); pMSCV‐Flag‐Bcl10 \[Addgene\#18718\] and the pcDNA3mycCARD9 \[Addgene\#162539\] (Addgene, Cambridge, MA USA); Renilla luciferase plasmid (pGL4.74\[*hRluc*/TK\]) and NF‐*κ*B reporter gene plasmid (pGL4.32\[luc2P/NF‐κB‐RE/Hygro\]) (Promega GmbH, Mannheim, Germany). The assay was performed as described in Supplementary Material.

Immunoprecipitation and immunoblot analysis {#cmi12597-sec-0019}
-------------------------------------------

Cells were lysed in RIPA buffer containing 1% of Triton X100. Co‐immuno‐precipitation and immunoblot analysis were performed as described previously (Sarantis and Gray‐Owen, [2012](#cmi12597-bib-0034){ref-type="ref"}). Syk was detected by the anti‐Syk antibody and precipitated CEACAM3 by mAb 308/3‐3.

Chromatin immunoprecipitation {#cmi12597-sec-0020}
-----------------------------

Chromatin immunoprecipitation was performed as has been described previously (Heyl *et al*., [2014](#cmi12597-bib-0016){ref-type="ref"}; Singer *et al*., [2014](#cmi12597-bib-0038){ref-type="ref"}), using anti‐NFκ‐B p65, anti‐cRel and anti‐polymeraseII antibodies, as well as the following primers for the CXCL8 promoter region (Forward5′‐AAGAAAACTTTCGTCATACTCCG‐3′; Reverse5′‐ TGGCTTTTTATATCATCACCCTAC‐3′).

RT‐PCR and qPCR analysis {#cmi12597-sec-0021}
------------------------

RNA was analysed as described in Supplementary Material.

Flow cytometry {#cmi12597-sec-0022}
--------------

Cells were stained using mouse IgG1 (control), anti‐CD11b and mAb anti‐CEACAM3 (308/3‐3) antibodies, anti‐Syk or anti‐phospho Syk antibodies at 5 µg/ml and 1:200 PE‐conjugated goat anti‐mouse IgG. Analysis was carried out using the [facsaria ii and bd facsdiva]{.smallcaps} Software v.6.1.3 (BD Biosciences) or [facscalibur]{.smallcaps} and [cellquest pro]{.smallcaps} Software BD Biosciences.

Oxidative burst fluorescence assay {#cmi12597-sec-0023}
----------------------------------

1x10^6^ cells in 200 µl medium were incubated in the dark with 10 µg/ml of 2′,7′Dihydrodichlorofluorescein diacetate (DHCF‐DA) (Sigma) for 30 min prior to infection with *M. catarrhalis* for 1 h at multiplicity of infection (MOI) 100. Thereafter cells were centrifuged, resuspended in PBS, and fluorescence was analysed by flow cytometry.

Myeloperoxidase activity assay {#cmi12597-sec-0024}
------------------------------

The MPRO activity assay was performed as has been described previously (Abdel‐Latif *et al*., [2004](#cmi12597-bib-0001){ref-type="ref"}). In brief, 5x10^6^ cells were re‐suspended in 500 µl of phenol red‐free medium and incubated for 5 min with 5 µg/ml of cytochalasin B prior to infection with *M. catarrhalis* for 1 h at MOI 50. 50 µl of supernatant were mixed with 150 µl of tetramethylbenzidine peroxidase substrate (BD Biosciences, Heidelberg, Germany). After 30 min, the reaction was stopped by adding 50 µl of 2 N H~2~SO~4~, and plates were read spectrophotometrically at 450 nm.

Statistical analysis {#cmi12597-sec-0025}
--------------------

The data shown in Figs [2](#cmi12597-fig-0002){ref-type="fig"}, [3](#cmi12597-fig-0003){ref-type="fig"}, [4](#cmi12597-fig-0004){ref-type="fig"}, [5](#cmi12597-fig-0005){ref-type="fig"}, [6](#cmi12597-fig-0006){ref-type="fig"} are mean ± SD from at least three independent experiments. Stimulatory effects of *M*. *catarrhalis*, as well as the inhibitory effects of blocking antibodies or siRNAs, were evaluated using one‐way analysis of variance followed by Newman--Keuls post‐test (Prism5, Graphpad Prism Inc.). *P* values below 0.05 were considered to be significant.
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Supporting information
======================

**Fig. S1.** Scanning electron micrographs (SEM) of the interaction of M. catarrhalis strain BBH18 with human granulocytes. Adherent M. catarrhalis form multi‐cellular, grape‐like aggregates (arrows) on the cell surface 2 h (A, B), 4 h (C) and 6 h (D) post‐infection (MOI 50). (E, F) Lamellipodia on human granulocytes in the presence of M. catarrhalis 2 h post‐infection (MOI 50). Bars represent 1 or 2 µm as indicated. Data are from two experiments.

**Fig. S2.** FISH of Moraxella culture (A, B, C) using the panbacterial probe EUB338Cy3 (orange), NONEUB338Cy5 (magenta, data not shown) and nucleic acid stain DAPI (blue). Note the differential FISH‐signal intensity indicating different 16S rRNA‐content of the cells. In particular bacteria that just divided show a bright FISH signal (arrows) due to a high ribosomal content. (A) overlay of the Cy3‐ and DAPIchannel. (B) Cy3‐channel only show the different signal intensities. (C) DAPI‐channel only. Likewise DAPI shows more bacteria within granulocytes (F, blue) than detected by the FISH‐probe (D, E orange). Supplementary Figures 1 D‐F show the identical microscopic field as Figure 1 C. For all images the identical magnification and identical exposure times were used for the respective fluorescence filter sets.

**Fig. S3.** UspA1 protein sequence alignments. Sequence analysis of CEACAM binding in UspA1 proteins. Alignment of variant sequences of UspA1 BBH18 is shown compared to UspA1 ATCC25238 and the known UspA1 deletion variant O35E spanning the CEACAM‐binding region of UspA1, which is delineated with a horizontal blue arrow above the sequences.

**Fig. S4.** (A) Moraxella uptake by granulocytes. TEM micrographs of granulocytes were taken 6 h after incubation with M.cat. MOI 50 with /without CEACAM3 blocking antibody 1h prior to infection. M.cat. uptake was estimated in 10 granulocytes per group (bars represent mean and SD) (B) PCR of granulocytes, ATRA‐differentiated and untreated NB4 cells.

**Fig. S5.** Proposed model for the CEACAM3‐mediated activation of the Card9‐dependent NF‐κB pathway. Bacterial binding to CEACAM3 results in recruitment and phosphorylation of Syk to the cytoplasmic ITAM domain of CEACAM3, which is followed by the activation of the Card9/Bcl10/Malt1 signalosome, which leads to NF‐κB activation and cytokine secretion.
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